Study Finds Pargluva May Increase Risk of Heart Attack or Stroke
(LegalNewsWatch) Pargluva, a proposed diabetes drug from Bristol-Myers Squibb and Merck & Company, appears to increase the risk of death, heart attack or stroke, according to a study published in a leading medical journal last week. The study was conducted by the
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 9068 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 9068]
updated 9068 (Legal News Watch), inserted 0, updated 0, at 2012-05-29 23:00:13
